Stocks and Investing
Stocks and Investing
Mon, April 22, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Daniel Grosslight Initiated (AGL) at Hold and Held Target at $6 on, Apr 22nd, 2024
Daniel Grosslight of Citigroup, Initiated "agilon health, inc." (AGL) at Hold and Held Target at $6 on, Apr 22nd, 2024.
Daniel has made no other calls on AGL in the last 4 months.
There are 10 other peers that have a rating on AGL. Out of the 10 peers that are also analyzing AGL, 6 agree with Daniel's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Jailendra Singh of "Truist Securities" Maintained at Hold with Decreased Target to $6.4 on, Monday, April 15th, 2024
- Elizabeth Anderson of "Evercore ISI Group" Maintained at Hold with Decreased Target to $6 on, Wednesday, February 28th, 2024
- Gary Taylor of "TD Cowen" Downgraded from Buy to Hold and Decreased Target to $6.5 on, Monday, February 26th, 2024
- Craig Jones of "Stifel" Maintained at Hold with Decreased Target to $9 on, Thursday, February 22nd, 2024
- Justin Lake of "Wolfe Research" Downgraded from Buy to Hold on, Monday, January 8th, 2024
- Lisa Gill of "JP Morgan" Downgraded from Buy to Hold and Decreased Target to $9 on, Friday, January 5th, 2024
These are the ratings of the 4 analyists that currently disagree with Daniel
- Andrew Mok of "Barclays" Initiated at Sell and Held Target at $5 on, Wednesday, March 6th, 2024
- Bill Sutherland of "Benchmark" Maintained at Strong Buy with Decreased Target to $9 on, Thursday, February 29th, 2024
- Sean Dodge of "RBC Capital" Maintained at Buy with Decreased Target to $8 on, Wednesday, February 28th, 2024
- Stephen Baxter of "Wells Fargo" Maintained at Buy with Decreased Target to $8 on, Monday, February 26th, 2024
Contributing Sources